EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of meningioma shrinkage after cyproterone acetate cessation

Annabelle Collin iD, Virginie Montalibet, Paul E Constanthin, Olivier Saut, Julien Engelhardt iD

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 25.06.2026. Verfasst von Annabelle Collin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mathematics Laboratory Jean Leray, UMR 6629, Nantes University, CNRS, Nantes, France (A.C.). Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progestin-induced meningiomas may stabilize or regress after discontinuation of cyproterone acetate (CPA), but the determinants of this volumetric response remain unclear. Identifying predictors of tumor shrinkage could improve patient management and prognosis.

Methods

We retrospectively analyzed the longitudinal volumetric evolution of 137 meningiomas diagnosed during ongoing CPA treatment in 52 consecutive patients. Tumor volumes were measured from all available imaging studies. Four mathematical models (linear, exponential, power, and the Gompertz) were compared to describe tumor growth trajectories. Response patterns were derived from the Gompertz modeling. Predictive models were constructed using random forests, with leave-one-out cross-validation. Baseline clinical and radiological variables, as well as early volumetric response at 3 months, were evaluated as predictors.

Results

The Gompertz model best described tumor volume evolution. Three patterns of tumor response after CPA withdrawal were identified: response with low limit volume (47%), response with high limit volume (41%), and non-response (12%). At the patient level, analogous clusters were found: low limit response (22%), high limit response (64%), and non-response (14%). Random forest models predicted cluster membership with error rates of 24.8% at the tumor level and 23.1% at the patient level. The most informative predictors were initial tumor burden and patient age at CPA exposure and withdrawal. Incorporating early volumetric response at 3 months reduced the prediction error to 9.5% for tumors and 3.8% for patients.

Conclusions

Tumor burden and age at CPA exposure are major predictors of meningioma shrinkage after treatment discontinuation. Early volumetric changes provide additional prognostic value and significantly improve predictive accuracy.

Schlagwörter

Stichwörter der Autor:innen

Gompertz modelcyproterone acetatemeningiomasprogesteronerandom forests

Autor:innen und Institutionen

  • Mathematics Laboratory Jean Leray, UMR 6629, Nantes University, CNRS, Nantes, France (A.C.).
  • Inria Center, Bordeaux University, team-project Monc, Talence, France.
  • Mathematics Institute of Bordeaux, UMR 5251, Bordeaux University, CNRS, Bordeaux INP, Talence, France.
  • Department of Neurosurgery, Bordeaux University Hospital, Bordeaux, France.

ORCID-Profile: Annabelle Collin, Julien Engelhardt

Zitieren

APA

Collin, A., Montalibet, V., Constanthin, P. E., Saut, O., & Engelhardt, J. (2026). Prediction of meningioma shrinkage after cyproterone acetate cessation. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag164

Vancouver

Collin A, Montalibet V, Constanthin PE, Saut O, Engelhardt J. Prediction of meningioma shrinkage after cyproterone acetate cessation. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag164

BibTeX
@article{Collin2026,
  author = {Collin, Annabelle and Montalibet, Virginie and Constanthin, Paul E and Saut, Olivier and Engelhardt, Julien},
  title = {Prediction of meningioma shrinkage after cyproterone acetate cessation},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag164}
}
Kostenlos starten →